LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation
Mi Young Park(SUNY Upstate Medical University), William G. Kerr(Amicus Therapeutics (United Kingdom))
Cited by 12
Related Papers
SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells
|The Journal of Immunology|2010|142
Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer
|Molecular Medicine|2011|112